Chadi welcomes back Alison Bateman-House, MPH, PhD, medical ethicist at New York University’s School of Medicine, to break down COVID-19 vaccine distribution and mandates.
Why has vaccine distribution not been an efficient and effective process? Are the right people being prioritized in the vaccine pecking order? Should vaccine doses be immediately available to anybody and everybody to make strides toward herd immunity? Should a “first dose only” vaccine approach be adopted to mitigate the supply shortage? Is a government mandate of the vaccine at any level legal and ethical? How about at schools or hospital systems? The duo dives into trying to make sense of the burning COVID-19 vaccine questions of today.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
